hsa-mir-1251: Hsa-mir-1251 is a microRNA that was analyzed in a study [PMC6921333]. In the study, several other microRNAs, including hsa-mir-383, hsa-mir-490, hsa-mir-488, hsa-mir-1912, hsa-mir-1265, and others were also examined [PMC6921333]. The expression variation tendency of these microRNAs was determined through bioinformatic analysis [PMC6921333]. Hsa-mir-1251 did not show a significant expression difference (P > 0.05) in comparison to the other microRNAs [PMC6921333]. Another study reported that hsa-miR-3591-3p, hsa-miR-122-3p and hsa-miR-122-5p were part of the miRNome of AG [PMC8900545]. In this study, the most deregulated miRNAs were found to be hsa-miR215, hsa-miR4497 and hsa-mir1251 [PMC8900545]. HSA-MIR1251 was also included in a chip that contained primers for various targets including HSA-MIR17 and HSA-MIR27A among others [PMC6308291]. The chip analysis revealed two groups of targets: one group with overall stable CNRQ values including HSA-MIR17 and HSA-MIR27A and another group with high CNRQ values at standard fixation conditions including RNU12 and RNU2.1 among others [PMC6308291]. Furthermore, another study found that 11 Down-regulated DEmiRNAs including HSA-MIR1251 could predict gene expression regulation in PCa (prostate cancer) [PMC8426106].